ATE41430T1 - 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen. - Google Patents

8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.

Info

Publication number
ATE41430T1
ATE41430T1 AT85111690T AT85111690T ATE41430T1 AT E41430 T1 ATE41430 T1 AT E41430T1 AT 85111690 T AT85111690 T AT 85111690T AT 85111690 T AT85111690 T AT 85111690T AT E41430 T1 ATE41430 T1 AT E41430T1
Authority
AT
Austria
Prior art keywords
sub
purine derivatives
processes
preparation
substituted nucleoside
Prior art date
Application number
AT85111690T
Other languages
German (de)
English (en)
Inventor
Silvano Casadio
Duccio Favara
Ezio Panto
Amadeo Omodei Sale
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Application granted granted Critical
Publication of ATE41430T1 publication Critical patent/ATE41430T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT85111690T 1984-09-20 1985-09-16 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen. ATE41430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti
EP85111690A EP0175325B1 (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ATE41430T1 true ATE41430T1 (de) 1989-04-15

Family

ID=11199882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85111690T ATE41430T1 (de) 1984-09-20 1985-09-16 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.

Country Status (14)

Country Link
US (1) US4774325A (no)
EP (1) EP0175325B1 (no)
JP (1) JPS61112077A (no)
AT (1) ATE41430T1 (no)
AU (1) AU591462B2 (no)
CA (1) CA1268175A (no)
DE (1) DE3568783D1 (no)
DK (1) DK167318B1 (no)
ES (1) ES8701773A1 (no)
GR (1) GR852261B (no)
IT (1) IT1196261B (no)
NZ (1) NZ213550A (no)
PT (1) PT81045B (no)
ZA (1) ZA857075B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
WO1994022864A1 (en) * 1993-03-30 1994-10-13 Sterling Winthrop Inc. Acyclic nucleoside analogs and oligonucleotide sequences containing them
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
WO2002069900A2 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
EP2336133A1 (en) * 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
JP3929949B2 (ja) * 2003-08-08 2007-06-13 独立行政法人科学技術振興機構 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法
EA010160B1 (ru) * 2003-09-18 2008-06-30 Конформа Терапьютикс Корпорейшн Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
NZ561939A (en) * 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
EP1937258A2 (en) * 2005-09-23 2008-07-02 Conforma Therapeutics Corporation Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE111312C (no) * 1897-12-16
US2819260A (en) * 1953-06-04 1958-01-07 Petrolite Corp Process for preparing oxyalkylated derivatives
US3391196A (en) * 1965-08-16 1968-07-02 Wyandotte Chemicals Corp High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols
GB1257546A (no) * 1968-09-10 1971-12-22
JPS5133799B2 (no) * 1973-06-14 1976-09-21
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
DE2631046A1 (de) * 1975-07-15 1977-01-20 Snam Progetti Adeninderivate und verfahren zu deren herstellung
SU883056A1 (ru) * 1980-03-26 1981-11-23 Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3169373D1 (en) * 1980-08-06 1985-04-25 Shell Int Research Process for the manufacture of polyether polyols and their use for preparing polyurethanes
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体

Also Published As

Publication number Publication date
EP0175325B1 (en) 1989-03-15
CA1268175A (en) 1990-04-24
DK167318B1 (da) 1993-10-11
NZ213550A (en) 1989-06-28
EP0175325A3 (en) 1987-02-04
JPH0569109B2 (no) 1993-09-30
IT8422739A0 (it) 1984-09-20
DK426185A (da) 1986-03-21
AU591462B2 (en) 1989-12-07
DE3568783D1 (en) 1989-04-20
IT1196261B (it) 1988-11-16
DK426185D0 (da) 1985-09-19
ES547856A0 (es) 1987-01-01
EP0175325A2 (en) 1986-03-26
PT81045A (en) 1985-09-01
ZA857075B (en) 1986-06-25
AU4767285A (en) 1986-03-27
JPS61112077A (ja) 1986-05-30
US4774325A (en) 1988-09-27
GR852261B (no) 1986-01-17
PT81045B (pt) 1987-09-18
ES8701773A1 (es) 1987-01-01
IT8422739A1 (it) 1986-03-20

Similar Documents

Publication Publication Date Title
ATE41430T1 (de) 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
ES8403128A1 (es) "un procedimiento para preparar derivados de purina".
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
CS960586A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
ATE75750T1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
ES8607271A1 (es) Amidinohidrazonas
PT80191A (en) Process for preparing substituted benzopyrans useful as medicaments
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
ATE7602T1 (de) Beta-d-arabinofuranosylimidazo(4,5-c)pyridinderivate und verfahren zu ihrer herstellung.
ATE56000T1 (de) Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate.
ATE40127T1 (de) 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel.
ATE26577T1 (de) 1-0-alkyl-3-amino-propan-1.2-diol-2-0phospholipide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE969T1 (de) Von desoxystreptamin abgeleitete aminoglykoside und ihre salze, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
ATE2897T1 (de) 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzaz pine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8700245A1 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
AU1226588A (en) A process for the preparation of 9-(hydroxyalkyl)-hypoxanthines
ATE82289T1 (de) 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
JPS5432469A (en) Novel imidazoline riboside derivatives and their preparation
EP0318060A3 (en) Griseolic acid derivatives, their preparation and their use
ES8605819A1 (es) Procedimiento de preparacion de nuevos derivados nucleosidos.
IT8719373A0 (it) Derivati fosfazenici di composti carbonilici atti all'impiego come fotoiniziatori di polimerizzazioni radicaliche.
ES8301991A1 (es) Procedimiento para la preparacion de 7-(2,6-dibromo-4-metil-fenil)-2,3-dihidro-imidazo 1,2-a, imidazoles.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee